Janus Henderson Group
LEGN icon

Janus Henderson Group’s Legend Biotech LEGN Stock Holding History

Janus Henderson Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,125,085
Closed -$69.3M – 2440
2025
Q3 		$69.3M Buy
2,125,085
+32,353
+2% +$1.19M 0.03% 349
2025
Q2 		$74.3M Buy
2,092,732
+34,928
+2% +$1.13M 0.04% 317
2025
Q1 		$72.2M Sell
2,057,804
-98,945
-5% -$3.55M 0.04% 308
2024
Q4 		$70.2M Sell
2,156,749
-28,885
-1% -$1.2M 0.04% 323
2024
Q3 		$107M Sell
2,185,634
-173,422
-7% -$9.24M 0.05% 271
2024
Q2 		$104M Buy
2,359,056
+345,044
+17% +$15.9M 0.06% 258
2024
Q1 		$113M Buy
2,014,012
+148,855
+8% +$8.98M 0.06% 245
2023
Q4 		$112M Buy
1,865,157
+131,379
+8% +$8.33M 0.07% 239
2023
Q3 		$116M Sell
1,733,778
-80,559
-4% -$5.6M 0.08% 228
2023
Q2 		$125M Sell
1,814,337
-124,754
-6% -$8.15M 0.08% 218
2023
Q1 		$93.5M Buy
1,939,091
+91,449
+5% +$4.47M 0.06% 260
2022
Q4 		$92.2M Sell
1,847,642
-1,877,106
-50% -$90.9M 0.07% 252
2022
Q3 		$152M Buy
3,724,748
+3,633,649
+3,989% +$171M 0.06% 280
2022
Q2 		$5.02M Buy
+91,099
New +$3.85M ﹤0.01% 843

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group's LEGN Position: Q4 2025 in Review

Janus Henderson Group sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 2,125,085 shares — an estimated $69.3M sold.

Janus Henderson Group first reported a position in LEGN in Q2 2022 and held it in 14 quarters. The position peaked at $152M in Q3 2022. 198 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Janus Henderson Group reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Janus Henderson Group sold 2,125,085 Legend Biotech shares in Q4 2025, an estimated $69.3M.
  • Janus Henderson Group first reported a position in Legend Biotech in Q2 2022 and held it in 14 quarters.
  • Janus Henderson Group's Legend Biotech position peaked at $152M in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.